martes, 8 de diciembre de 2020

Best Practices in Developing Proprietary Names for Human Nonprescription Drug Products; Draft Guidance for Industry | FDA

Best Practices in Developing Proprietary Names for Human Nonprescription Drug Products; Draft Guidance for Industry | FDA

No hay comentarios: